‘It’s a real-life Hunger Games’: a lifesaving drug costs $2m, but not every child can get it
By Hannah Devlin,
The Guardian
| 03. 05. 2022
Photo by Nathan Dumlao on Unsplash
Elizabeth Wraige remembers the first time she delivered the diagnosis. “Parents feel as if they’ve been hit by a sledgehammer,” she says. Her patient, a baby boy, had been born tiny and perfect to overjoyed parents six months earlier. But they had begun to feel something was not right. He seemed floppy and was not moving normally. Tests showed he had spinal muscular atrophy (SMA), the most deadly genetic condition in children under two, in which a deficit of a crucial protein causes motor neurons to die, and the body slowly loses the ability to move. Babies with untreated type 1 SMA, the most severe form, will never sit, crawl or speak and are slowly robbed of the ability to move, swallow and breathe. Most die before they are two.
“In that conversation, any hope that it was something that could be remedied was taken away,” says Wraige, a paediatric neurologist at Evelina London children’s hospital. “It was devastation.” She could offer only one shred of consolation: SMA, an incurable condition...
Related Articles
By Fyodor Urnov, Time | 08.12.2024
After a lifetime in the field of epigenetics, and nearly 20 years after my colleagues and I coined the term “genome editing,” I will be the first to admit that describing the “epigenome”—a marvelous biological process that guides...
By Joy Zhang, Progress Educational Trust | 08.12.2024
What do China's new ethical guidlines tell us about the country's changing attitude to human genome editing? Professor Joy Zhang reads between the lines...
Recently, China's National Science and Technology Ethics Committee introduced a new set of ethics guidelines on...
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...